New Horizon Health Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Yeqing Zhu
Algemeen directeur
CN¥48.8m
Totale compensatie
| Percentage CEO-salaris | 8.3% |
| Dienstverband CEO | 6yrs |
| Eigendom CEO | 3.4% |
| Management gemiddelde ambtstermijn | 6yrs |
| Gemiddelde ambtstermijn bestuur | 3.3yrs |
Recente managementupdates
Recent updates
New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable
Mar 04
Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?
Jan 30Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?
Sep 28New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News
Sep 28Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet
Aug 02New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)
Jul 14News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts
Mar 19Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%
Jan 13News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts
Mar 23Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues
Jan 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | CN¥112m |
| Mar 31 2023 | n/a | n/a | CN¥16m |
| Dec 31 2022 | CN¥49m | CN¥4m | -CN¥79m |
| Sep 30 2022 | n/a | n/a | -CN¥169m |
| Jun 30 2022 | n/a | n/a | -CN¥259m |
| Mar 31 2022 | n/a | n/a | -CN¥2b |
| Dec 31 2021 | CN¥14m | CN¥3m | -CN¥3b |
Compensatie versus markt: De totale vergoeding ($USD 6.73M ) Yeqing } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 479.01K ).
Compensatie versus inkomsten: De vergoeding van Yeqing is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Yeqing Zhu (52 yo)
6yrs
Tenure
CN¥48,829,000
Compensatie
Mr. Yeqing Zhu serves as Executive Chairman at New Horizon Health Limited since June 20, 2022. He is the Chief Executive Officer of New Horizon Health Ltd. since June 7, 2018.Mr. Zhu is an Executive Direc...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, Executive Chairman & Co-founder | 6yrs | CN¥48.83m | 3.36% HK$ 213.4m | |
| Executive Director & Chief Scientific Officer | 6yrs | CN¥11.04m | 8.14% HK$ 516.4m | |
| CFO & Joint Company Secretary | 4yrs | geen gegevens | geen gegevens | |
| Chief Technology Officer | 8.6yrs | geen gegevens | geen gegevens | |
| Joint Company Secretary | 3.4yrs | geen gegevens | geen gegevens |
6.0yrs
Gemiddelde duur
52yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 6606 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, Executive Chairman & Co-founder | 6yrs | CN¥48.83m | 3.36% HK$ 213.4m | |
| Executive Director & Chief Scientific Officer | 6yrs | CN¥11.04m | 8.14% HK$ 516.4m | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | geen gegevens | |
| Non-executive Director | 5.9yrs | geen gegevens | 5.14% HK$ 325.9m | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | geen gegevens | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | geen gegevens |
3.3yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 6606 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).